The Recall Desk
ModerateFDA (Drugs)·D-059-2013·Announced 2012-11-28

Dr. Reddy's Quetiapine Fumarate Tablets Recalled for Dissolution Failure

Dr. Reddy's is recalling Quetiapine Fumarate Tablets, 25mg, because they failed USP dissolution testing during stability studies.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, and the source text does not report any illnesses or injuries, fitting the criteria for a moderate severity score.

Plain-English summary

Dr. Reddy's Laboratories, Inc. is recalling Quetiapine Fumarate Tablets, 25mg, Rx Only, 500 tablets (NDC 55111-249-05). The recall involves 1,512 bottles of Lot C203090 with an expiration date of 03/14. The product was distributed nationwide with no foreign consignees.

The recall was initiated because the product failed USP Dissolution Test Requirements. During the analysis of long-term stability studies at the 3-month time point, an out-of-specification (OOS) result was reported for the Quetiapine Fumarate Tablets, 25 mg.

Consumers and healthcare providers should stop using the affected product and contact their pharmacist or Dr. Reddy's Laboratories for further instructions or a replacement.

The recalled product

Product
Dr. Reddy's Quetiapine Fumarate Tablets, 25mg, Rx Only, 500 tablets. Mfd By: Dr. Reddy's Laboratories Limited, Bachepalli - 502 325, India NDC 55111-249-05
Manufacturer
Dr. Reddy's Laboratories, Inc.
Category
Drug — Prescription Medication
Hazard
Affected units
1,512

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Lot C203090 Exp.03/14

Distribution

Distributed nationwide across the United States.

Related recalls

Same manufacturer · Dr. Reddy's Laboratories, Inc.

See all →

Same hazard · quality failure

See all →